Rob Kent

Strategic Advisor at CureMetrix

Robert Kent is a seasoned professional in business development, currently serving as Senior Director of Business Development at Southern Star Research since November 2023. With a focus on enhancing the efficiency of clinical trials in the biopharmaceutical and medical device sectors in Australia and the Asia-Pacific region, Robert brings extensive experience from previous roles at AliveCor Inc., Premier Research, and Spaulding Clinical. Robert's background includes significant positions at Quintiles, where responsibilities ranged from Senior Director of Business Development for Cardiac Safety Services to Operations Director for Quintiles/Cardiac Alert. Robert began the career as a Registered Nurse and Charge Nurse in the Cardiothoracic Critical Care Unit at Chelsea and Westminster Hospital NHS Foundation Trust. Education was completed at the Wolfson School of Nursing from 1988 to 1991.

Links